DJIA 17,696.25 -79.87 -0.45%
NASDAQ 4,865.42 -35.46 -0.72%
S&P 500 2,059.61 -8.28 -0.40%
market minute promo

AbbVie Inc. (NYSE: ABBV)

56.78 -1.76 (-3.01%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

ABBV $56.78 -3.01%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $58.48
Previous Close $58.54
Daily Range $56.75 - $58.49
52-Week Range $45.50 - $70.76
Market Cap $90.5B
P/E Ratio 53.22
Dividend (Yield) $2.04 (3.5%)
Ex-Dividend Date
Dividend Pay Date
04/13/15
05/15/15
Volume 3,263,614
Average Daily Volume 12,459,583
Current FY EPS $4.34

Sector

Industry

AbbVie Inc. (ABBV) Description

AbbVie Inc. Website: http://www.abbvie.com/

News & Commentary Rss Feed

The Single Worst Practice of the Drug Industry

Pay for delay is a legal maneuver Big Pharma uses to keep generic drugs off the market. According to the FTC, it costs consumers and taxpayers $3.5 billion every year.

AmerisourceBergen: A Great Growth Story

The Zacks Analyst Blog Highlights: Google, Johnson & Johnson, AbbVie, Yahoo and Microsoft - Press Re

The Zacks Analyst Blog Highlights: Google, Johnson & Johnson, AbbVie, Yahoo and Microsoft - Press Releases

Biogen/AbbVie's MS Drug Zinbryta Under Review in the EU - Analyst Blog

Healthcare Merger Monday: These 3 Stocks Could Be Healthcare's Next Buyout Targets

Our experts weigh in.

Biotech Merger Monday Doesn't Squash Biotech Bubble Debate

Is Gilead Sciences Inc. About to Crater Before Our Very Eyes?

Gilead Sciences has become a battleground stock due to the uncertainty surrounding the future of the hep C market. Here is a look at why the bears might be right in their assessment of this top biotech stock.

Biotech, Chips Stand Their Ground; Be Careful What You Wish For: Jim Cramer's Best Blogs

7 of the Most Audacious 'Moonshot' Projects From Google, Amazon and Facebook

US Stock Futures Edge Lower Ahead Of GDP, Consumer Sentiment Data

See More ABBV News...